EUVIMEDEUVIMED entdecken
Fallbericht

Hookworm Anthelmintic Resistance: Novel Fecal Polymerase Chain Reaction Ancylostoma caninum Benzimidazole Resistance Marker Detection in a Dog

Michelle Evason, Emilio DeBess, Nicole Culwell, Jennifer Ogeer, Christian Leutenegger

Journal of the American Animal Hospital Association · 2024

DOI: 10.5326/jaaha-ms-7366 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of the American Animal Hospital Association, 2024. Verfasst von Michelle Evason und 4 weiteren Autor:innen. Beteiligte Einrichtung: From Antech Diagnostics, Fountain Valley, California (Evason, Culwell, Ogeer, Leutenegger); and. Hauptthemen laut MEDLINE: Dog Diseases, Anthelmintics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A 4 yr old castrated male greyhound presented with a history of chronic (>3 wk) intermittent diarrhea. Initial fecal analysis identified infection with Ancylostoma caninum . Despite treatment with routine anthelmintics, the dog remained persistently A caninum positive for several months. A novel fecal gastrointestinal real-time polymerase chain reaction (qPCR) parasite panel detected A caninum and the genetic benzimidazole (BZ) F167Y resistance marker in multiple samplings over 48 hr. This finding, together with the dog’s clinical signs (diarrhea) and lack of response to routine anthelmintics, prompted treatment with cyclooctadepsipeptide emodepside, a drug currently not registered for dogs in the United States. The dog’s clinical signs resolved and post-treatment fecal qPCR testing was negative. However, 5 mo later, retesting with fecal qPCR detected A caninum and concurrent BZ resistance marker, as well as Giardia . A presumptive diagnosis of re-infection was made and the emodepside treatment was continued. The dog again reverted to undetected ( A caninum and the 167 resistance marker) on reassessment fecal qPCR. This case report describes the use of a novel fecal qPCR panel for gastrointestinal parasites, persistent hookworm and BZ F167Y resistance marker detection in a dog, and highlights the importance of a stepwise approach to clinical management, treatment, and retesting.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dog DiseasesAnthelminticsDogsMaleAnimalsUnited StatesAncylostomaAncylostomatoideaBenzimidazolesFecesPolymerase Chain ReactionDiarrhea

Substanzen

AnthelminticsBenzimidazoles

Autor:innen und Institutionen

  • From Antech Diagnostics, Fountain Valley, California (Evason, Culwell, Ogeer, Leutenegger); and.
  • Oregon State Public Health Department, Portland, Oregon (DeBess).

Zitieren

APA

Evason, M., DeBess, E., Culwell, N., Ogeer, J., & Leutenegger, C. (2024). Hookworm Anthelmintic Resistance: Novel Fecal Polymerase Chain Reaction Ancylostoma caninum Benzimidazole Resistance Marker Detection in a Dog. Journal of the American Animal Hospital Association. https://doi.org/10.5326/jaaha-ms-7366

Vancouver

Evason M, DeBess E, Culwell N, Ogeer J, Leutenegger C. Hookworm Anthelmintic Resistance: Novel Fecal Polymerase Chain Reaction Ancylostoma caninum Benzimidazole Resistance Marker Detection in a Dog. Journal of the American Animal Hospital Association. 2024. doi:10.5326/jaaha-ms-7366

BibTeX
@article{Evason2024,
  author = {Evason, Michelle and DeBess, Emilio and Culwell, Nicole and Ogeer, Jennifer and Leutenegger, Christian},
  title = {Hookworm Anthelmintic Resistance: Novel Fecal Polymerase Chain Reaction Ancylostoma caninum Benzimidazole Resistance Marker Detection in a Dog},
  journal = {Journal of the American Animal Hospital Association},
  year = {2024},
  doi = {10.5326/jaaha-ms-7366}
}
Kostenlos starten →